Stock Events

Stock Events

Integra Lifesciences 

$16.27
11
-$0.17-1.03% 13:33 Today

Statistics

Day High
16.27
Day Low
16.27
52W High
20.49
52W Low
8.7
Volume
85
Avg. Volume
-
Mkt Cap
1.27B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.4
0.59
0.78
0.97
Expected EPS
0.563768
Actual EPS
N/A

Financials

-31.58%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.64BRevenue
-516.47MNet Income

Analyst Ratings

18.80Average Price Target
The highest estimate is 19.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IART. It's not an investment recommendation.
Altria Group
5
MO
Realty Income
4
O
Johnson & Johnson
4
JNJ
AT&T
4
T

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation competes directly with Integra Lifesciences in the medical technology and surgical instruments sector, offering similar products for neurosurgery and orthopedics.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers a wide range of medical devices that compete with Integra's offerings, especially in the neurosurgery and spinal products market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical products and wound care, overlapping with Integra's product lines.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and neurosurgery sectors, offering products that directly compete with Integra's surgical instruments and implants.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers products in the neuromodulation and neurovascular sectors, competing with Integra Lifesciences' neurosurgical product lines.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic surgery products, competing with Integra's offerings.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra Lifesciences competes with itself through its diverse range of products, constantly innovating and expanding its portfolio to stay competitive in the market.
Alphatec
ATEC
Mkt Cap1.46B
Alphatec Holdings, Inc. is a provider of spinal surgery solutions, competing in the same space as Integra Lifesciences with its focus on innovative spinal products and technologies.

About

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Show more...
CEO
Stuart Essig
Employees
4427
Country
United States
ISIN
US4579852082
WKN
000897013

Listings

STU
DE
IL3.STU
MU
DE
IL3.MU
BOATS
BOATS
IART.BOATS
F
DE
IL3.F

0 Comments

Share your thoughts

FAQ

What is Integra Lifesciences stock price today?▼
The current price of IART is $16.27 USD — it has decreased by -1.03% in the past 24 hours. Watch Integra Lifesciences stock price performance more closely on the chart.
What is Integra Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Integra Lifesciences stocks are traded under the ticker IART.
Is Integra Lifesciences stock price growing?▼
IART stock has fallen by -2.66% compared to the previous week, the month change is a -8.16% fall, over the last year Integra Lifesciences has showed a +5.05% increase.
What is Integra Lifesciences market cap?▼
Today Integra Lifesciences has the market capitalization of 1.27B
When is the next Integra Lifesciences earnings date?▼
Integra Lifesciences is going to release the next earnings report on November 04, 2026.
What were Integra Lifesciences earnings last quarter?▼
IART earnings for the last quarter are 0.56 USD per share, whereas the estimation was 0.48 USD resulting in a +16.54% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Integra Lifesciences revenue for the last year?▼
Integra Lifesciences revenue for the last year amounts to 1.64B USD.
What is Integra Lifesciences net income for the last year?▼
IART net income for the last year is -516.47M USD.
How many employees does Integra Lifesciences have?▼
As of September 04, 2026, the company has 4,427 employees.
In which sector is Integra Lifesciences located?▼
Integra Lifesciences operates in the Health & Wellness sector.
When did Integra Lifesciences complete a stock split?▼
The last stock split for Integra Lifesciences was on January 04, 2017 with a ratio of 2:1.
Where is Integra Lifesciences headquartered?▼
Integra Lifesciences is headquartered in PRINCETON, United States.